hUCMSCs restore ovarian function via angiopoietin 1/2 rebalance in POI rats
Open Access
- 18 November 2025
- journal article
- Published by Springer Nature in Journal of Ovarian Research
- Vol. 18 (1) , 269
Abstract
Background Premature ovarian insufficiency (POI) is often iatrogenic and the therapeutic potential of human umbilical cord derived mesenchymal stem cells (hUCMSCs) remain incompletely defined. This study aimed to evaluate the effects and underlying mechanism of hUCMSCs on ovarian function in a rat model of POI. Methods hUCMSCs were characterized by morphology, flow cytometry, and multi-lineage differentiation assays. POI was induced in rats using cyclophosphamide (CTX), followed by intravenous administration of hUCMSCs. Therapeutic outcomes were assessed through cell homing analysis, ovarian histopathology, and serum hormone measurements. Bioinformatic analysis identified Angiopoietin 1 (Angpt1) as a key angiogenic regulator, which was validated by western blot and qRT-PCR. Rat ovarian microvascular endothelial cells (ROMECs) were isolated and functionally assessed under CTX and hUCMSCs treatment using wound healing, tube formation, and evaluation of the Angpt1 and Angpt2 balance. Results In vivo, hUCMSCs preferentially homed to the ovarian theca layer and restored ovarian function. The Angpt1/ Angpt2 ratio was markedly reduced in POI rats but significantly increased after hUCMSCs treatment, and the ratio positively correlated with CD31 expression. In vitro, CTX impaired ROMECs migration and angiogenic capacity, whereas coculture with hUCMSCs rescued these functions and restored the Angpt1/Angpt2 ratio. Conclusion hUCMSCs ameliorate ovarian dysfunction in POI by modulating the Angpt1/Angpt2 axis, thereby enhancing vascular homeostasis and angiogenesis within the ovarian microenvironment. These findings provided mechanistic insights supporting the clinical translation of hUCMSCs-based therapies for POI.Keywords
Funding Information
- Natural Science Foundation of Shandong Province (ZR2021QH149, ZR2022QC082)
- TCM Science and Technology Project of Shandong Province (Q2023057)
This publication has 47 references indexed in Scilit:
- Human umbilical cord mesenchymal stem cells alleviate chemotherapy-induced premature ovarian insufficiency mouse model by suppressing ferritinophagy-mediated ferroptosis in granulosa cellsFree Radical Biology and Medicine, 2024
- hUMSCs Transplantation Regulates AMPK/NR4A1 Signaling Axis to Inhibit Ovarian Fibrosis in POI RatsStem Cell Reviews and Reports, 2022
- Ovarian protection with gonadotropin-releasing hormone agonists during chemotherapy in cancer patients: From biological evidence to clinical applicationCancer Treatment Reviews, 2019
- Advances in the Molecular Pathophysiology, Genetics, and Treatment of Primary Ovarian InsufficiencyTrends in Endocrinology & Metabolism, 2018
- Hormone replacement therapy in young women with primary ovarian insufficiency and early menopauseFertility and Sterility, 2016
- Premature ovarian insufficiency: from pathogenesis to clinical managementJournal of Endocrinological Investigation, 2015
- Platelet‐derived growth factor BB and DD and angiopoietin1 are altered in follicular fluid from polycystic ovary syndrome patientsMolecular Reproduction and Development, 2014
- Angiopoietin 1 and angiopoietin 2 in follicular fluid of women undergoing a long protocolFertility and Sterility, 2011
- Angiopoietin 1 reduces rat follicular atresia mediated by apoptosis through the PI3K/Akt pathwayMolecular and Cellular Endocrinology, 2011
- Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression CloningCell, 1996